Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BR

Bernard Roizman — 39 Patents

ADArch Development: 23 patents #3 of 350Top 1%
TCThe University Of Chicago: 10 patents #30 of 1,377Top 3%
TFThe Uab Research Foundation: 2 patents #199 of 813Top 25%
IMInstitut Merieux: 2 patents #7 of 35Top 20%
MLMedimmune Limited: 1 patents #469 of 738Top 65%
AVAviron: 1 patents #5 of 11Top 50%
UPUniversity Patents: 1 patents #72 of 224Top 35%
Chicago, IL: #174 of 13,327 inventorsTop 2%
Illinois: #1,310 of 84,256 inventorsTop 2%
Overall (All Time): #81,245 of 4,157,543Top 2%
39 Patents All Time
Bernard Roizman has been granted 39 US patents while listed as an inventor at Arch Development. The first was granted in 1985 and the most recent in June 2021. Bernard Roizman ranks #81,245 of 4,157,543 US inventors in our database (top 2.0%). Patent records list Bernard Roizman in Chicago, IL, US.

Issued Patents All Time

Showing 1–25 of 39 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11026990 PUM 1 protein as target for virus inhibition Grace Guoying Zhou, Yonghong Liu 2021-06-08
10561708 Anti-tumor therapy Nikolai Khodarev, Ravi Sood, Ralph R. Weichselbaum 2020-02-18
9803006 Targeting of herpes simplex virus to specific receptors Guoying Zhou 2017-10-31
9790504 Anti-tumor therapy Nikolai Khodarev, Ravi Sood, Ralph R. Weichselbaum 2017-10-17
9669036 Modulation of reactivation of a latent virus Guoying Zhou, Te Du 2017-06-06
8927251 Targeting of herpes simplex virus to specific receptors Guoying Zhou 2015-01-06
8772261 Treatment of tumors with genetically engineered herpes virus Ralph R. Weichselbaum, Richard J. Whitley 2014-07-08
8318691 Treatment of tumors with genetically engineered herpes virus Ralph R. Weichselbaum, Richard J. Whitley 2012-11-27
7892740 Prognosis and therapy predictive markers and methods of use Ralph R. Weichselbaum, Andy Minn, Nikolai Khodarev, Edwardine Labay 2011-02-22
7744899 Recombinant herpes simplex virus useful for treating neoplastic disease Richard J. Whitley 2010-06-29
7592169 Methods and compositions for treatment and prevention of HSV-2 infections and conditions Richard Spaete, George Kemble, Mark N. Prichard 2009-09-22
7550148 Targeting of Herpes simplex virus to specific receptors Guoying Zhou 2009-06-23
7501126 Targeting of herpes simplex virus to specific receptors Gouying Zhou, Guo-Jie Ye 2009-03-10
6846670 Genetically engineered herpes virus for the treatment of cardiovascular disease Lewis B. Schwartz, Ralph R. Weichselbaum 2005-01-25
6723511 Herpes simplex virus ICP4 is an inhibitor of apoptosis Rosario Leopardi 2004-04-20
6410704 Methods and compositions for the preparation and use of a herpes protease Fenyong Liu 2002-06-25
6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis Renato Bruni 2002-05-07
6340673 Method of treating tumorigenic disease Joany Chou 2002-01-22
6218103 Herpes simplex virus US3 and ICP4 as inhibitors of apoptosis Rosario Leopardi 2001-04-17
6210926 Herpes simplex virus ICP4 is an inhibitor of apoptosis Rosario Leopardi 2001-04-03
6172047 Method of screening candidate protective, potentiating, or inhibiting substances Joany Chou 2001-01-09
6120773 Recombinant herpes simplex viruses vaccines and methods 2000-09-19
6071692 Herpes simplex virus as a vector 2000-06-06
5922328 Methods and compositions for treatment of HSV-2 infections and conditions Frances C. Spector, Richard Spaete 1999-07-13 $8,443,000
5876923 Herpes simplex virus ICP4 as an inhibitor of apoptosis Rosario Leopardi 1999-03-02